Adventris Pharmaceuticals
Adventris makes cancer vaccines
Baltimore, United States · Founded 2022
- Headquarters
- Baltimore, Maryland
- Employees
- 1–10
- Founded
- 2022
- Website
- adventris.com
- Last Round
- Convertible NoteJan 2023
- Rounds
- 1
About
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Summary
Adventris Pharmaceuticals is a Biotech company based in Baltimore, United States, founded in 2022. Its most recent funding was a Convertible Note round in Jan 2023. Investors include Y Combinator Continuity Fund and Refactor Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...